Faculty

Alison Drake

Adjunct Associate Professor, Epidemiology
Associate Professor, Global Health

206-543-5847

Education

PhD Epidemiology, University of Washington, 2010
MPH Epidemiology, University of Michigan, 2002
BS Microbiology, University of Michigan, 2000

Contact

206-543-5847

University of Washington Department of Global Health 3980 15th Ave NE Rm 884
Box 351620
Seattle, WA 98195

Bio

Alison Drake, MPH, PhD is an epidemiologist and Associate Professor at the University of Washington in the Department of Global Health. She is currently an Assistant Director of the Global Center for Integrated Health of Women, Adolescent, and Children (Global WACh) and co-Director of the Family Planning Decision Support Scientific Priority Area for Global WACh. Dr. Drake’s research interests include HIV prevention among women and adolescents, incident maternal HIV infections, vertical HIV transmission, adolescent reproductive health, mobile health, and family planning. She is the PI for an R01 testing a mobile health counseling intervention to reduce contraceptive discontinuation and help women living with HIV achieve their reproductive health goals in a randomized clinical trial in Kenya. She is also a co-PI of 2 studies on COVID-19 prevalence, household transmission, and antibody response among pregnant women and their household members in the Seattle area. In addition, she is a co-instructor for two courses in the School of Public Health, Responsible Conduct of Research: Global to Local and Global Perspectives on Reproductive Health.

Research Interests

  • HIV
  • Material & child health
  • Infections during pregnancy
  • Vertical HIV transmission
  • Family planning 
  • Reproductive health

Recent Publications (PubMed)

Preferences and uptake of home-based HIV self-testing for maternal retesting in Kenya.
(2024 Mar 30)
medRxiv
Drake AL, Jiang W, Kitao P, Farid S, Richardson BA, Katz DA, Wagner AD, Johnson CC, Matemo D, Stewart GJ, Kinuthia J

Mobile solutions to Empower reproductive life planning for women living with HIV in Kenya (MWACh EMPOWER): Protocol for a cluster randomized controlled trial.
(2024)
PLoS One 19(4): e0300642
Ngumbau N, Unger JA, Wandika B, Atieno C, Beima-Sofie K, Dettinger J, Nzove E, Harrington EK, Karume AK, Osborn L, Sharma M, Richardson BA, Seth A, Udren J, Zanial N, Kinuthia J, Drake AL

Hybrid Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection or Vaccination Alone.
(2024 Apr 12)
J Infect Dis 229(4): 1241-1243
LaCourse SM, Wetzler EA, Aurelio MC, Escudero JN, Selke SS, Greninger AL, Goecker EA, Barnes SR, Arnould IS, Pérez-Osorio AC, Richardson BA, Kachikis A, Englund JA, Drake AL

Hybrid immunity to SARS-CoV-2 during pregnancy provides more durable infant antibody responses compared to natural infection alone.
(2023 Dec 21)
J Infect Dis
LaCourse SM, Wetzler EA, Aurelio MC, Escudero JN, Selke SS, Greninger AL, Goecker EA, Barnes SR, Arnould IS, Pérez-Osorio AC, Richardson BA, Kachikis A, Englund JA, Drake AL

HIV Viral Load Patterns and Risk Factors Among Women in Prevention of Mother-To-Child Transmission Programs to Inform Differentiated Service Delivery.
(2024 Mar 1)
J Acquir Immune Defic Syndr 95(3): 246-254
Jiang W, Ronen K, Osborn L, Drake AL, Unger JA, Matemo D, Richardson BA, Kinuthia J, John-Stewart G

Show complete publication list